HawkCell
AI-enabled medical imaging for animals
- 1-20 employees
- Healthcare
- B2B
- Artificial Intelligence
- Pets
- Biology
- SaaS
- MedTech
- Le Bourg - Gare De Vaise, Lyon, France
Jump to section
Company mission
To make the healthcare industry more efficient and sustainable.
Our take
HawkCell looks to reshape veterinary care and preclinical research through advancements in animal MRI imaging. Its product introduces a patented plug-and-play solution that adapts human MRI technology into animal-dedicated systems for veterinary clinics and research laboratories.
HawkCell integrates hardware solutions and AI powered software to deliver swift and precise analyses across various medical disciplines. With strategic partnerships established with leading MRI manufacturers, HawkCell has emerged as the exclusive provider of augmented MRI solutions, addressing a market valued at $700 million and growing.
The startup recently celebrated a significant milestone with the successful closure of its Series A funding. This funding will allow the company to propel its expansion efforts into the lucrative North American and Asian markets, allowing it to take on the redefinition of veterinary care on a global scale.
Freddie
Company Specialist at Welcome to the Jungle
Funding (2 rounds)
Mar 2024
$5.7m
SERIES A
Feb 2021
$0.9m
SEED
Total funding: $6.6m
Leadership
Hugo Dorez
(CSO & COO)Also the Founder and General Manager of Prisme Lab. Previously worked as a Biomedical Engineer at Alpes Léman Hospital Center.